Infographic: Maintaining data integrity
Posted: 14 July 2020 | Beckman Coulter | No comments yet
Maintaining Data Integrity. Did you know that lack of data integrity has been a top reason for FDA Drug GMP warning letters?
Records should include an electronic ‘signature’ to link them to the instrument/person that made the measurement. Compliant systems automatically track who and when a record was created, changes made, and the reason a change was made.
Related content from this organisation
- Direct quantitative analysis of biological particles using the Coulter Principle
- Product hub: Vi-CELL BLU cell viability/counting analyser
- Whitepaper: Characterising insulin as a biopharmaceutical using Analytical Ultracentrifugation
- Product hub: New MET ONE 3400+ air particle counter
- Data sheet: Viral RNA extraction from saliva and swab samples
Related topics
Biopharmaceuticals, Data integrity, Drug Delivery Systems, Environmental Monitoring, Good Manufacturing Practice (GMP), Manufacturing, QA/QC, Research & Development (R&D)
